Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Patient Tracking Report – Wave 3

October 26, 2020

As the novel coronavirus (COVID-19) pandemic continues to develop in the US, InCrowd wanted to understand how the experiences, perceptions, and predictions of patients who are immunocompromised or have chronic conditions have evolved over the course of this crisis.

We’d like to thank our friends at Rare Patient Voice for their help in sourcing this important research.


  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Patients with Mild to Severe Illnesses
  • Sample Size:
    • 152 Total Patients (Previous Waves: 159, 152)
      • 84 Mild to Moderate Patients (Previous Wave: 83, 77)
      • 68 Moderate to Severe Patients (Previous Wave: 76, 75)
  • Fielding Period:
    • October 7th – 8th

InCrowd’s other COVID-19 Tracking Reports:

    InCrowd uses the information you provide to us to contact you about our relevant insights, products, and services. You may opt out of communications at any time via the unsubscribe link at the bottom of any email or by sending an email withdrawing your consent to Send Email. For more information, please review our Privacy Policy.
  • This field is for validation purposes and should be left unchanged.